Point72 Middle East FZE’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-293
Closed -$6.42K 1140
2023
Q1
$6.42K Buy
+293
New +$6.42K ﹤0.01% 959